| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.072 | 0.07 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.52 | 0.07 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.08 |